Alternative pathway diagnostics-Reference-Cited by-同舟云学术

Alternative pathway diagnostics

Published:2022-10-28 Issue:1 Volume:313 Page:225-238
ISSN:0105-2896
Container-title:Immunological Reviews
language:en
Short-container-title:Immunological Reviews

Author:

Thurman Joshua M.¹^ORCID,Fremeaux‐Bacchi Veronique²

Affiliation:

1. Department of Medicine University of Colorado School of Medicine Aurora Colorado USA

2. Assistance Publique‐Hôpitaux de Paris European Hospital Georges Pompidou Department of Immunology Biology and INSERM UMRS1138 Centre de Recherche des Cordeliers, Team "Inflammation, Complement and Cancer" Paris France

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Institutes of Health

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imr.13156

Reference127 articles.

1. The Properdin System and Immunity: I. Demonstration and Isolation of a New Serum Protein, Properdin, and Its Role in Immune Phenomena

2. Genetic studies into inherited and sporadic hemolytic uremic syndrome

3. Diseases of complement dysregulation—an overview

4. A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice

5. Antibody Inhibition of Properdin Prevents Complement-Mediated Intravascular and Extravascular Hemolysis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Usefulness and analytical performances of complement multiplex assay for measuring complement biomarkers in plasma;Clinica Chimica Acta;2024-02

2. The role of complement in kidney disease;Nature Reviews Nephrology;2023-09-21

3. Heme Interactions as Regulators of the Alternative Pathway Complement Responses and Implications for Heme-Associated Pathologies;Current Issues in Molecular Biology;2023-06-16

4. An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndrome;Frontiers in Immunology;2023-02-09

5. The complement alternative pathway in health and disease—activation or amplification?;Immunological Reviews;2022-11-24